Fibronostics and the Fatty Liver Foundation are pleased to announce they have entered into a strategic collaboration, combining Fibronostics' industry…
Fibronostics, a global company providing non-invasive, algorithmic diagnostics for NASH patients, announced that it has secured $8 million in series A…